VAERS Explorer
Back to explore

Report #2860248

Received Sep 22, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
Apr 1, 2025
Onset
Apr 1, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (MODERNA))MODERNAUNK—IM

Symptoms (1)

Skin exfoliation

Symptom narrative

her feet significantly peeled; This spontaneous case was reported by a consumer and describes the occurrence of SKIN EXFOLIATION (her feet significantly peeled) in a female patient of an unknown age who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) for COVID-19 prophylaxis. No Medical History information was reported. In April 2025, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) 1 dosage form. In April 2025, the patient experienced SKIN EXFOLIATION (her feet significantly peeled). At the time of the report, SKIN EXFOLIATION (her feet significantly peeled) outcome was unknown. No concomitant medication was reported. It was reported that after last vaccine in Apr-2025 patient feet were significantly peeled. It was unknown if the patient experienced any additional symptoms or events. Reporter causality was not provided. No treatment medication was reported. Reporter did not allow further contact